Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - October 27.05.2026 FOCT.LN IE0004X8KUG5 100,002.00 USD 2,901,885.55 29.018  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 27.05.2026 FJUL.LN IE000YJBT6I5 100,002.00 USD 2,829,885.33 28.298  ...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....

MUNICH, Germany--(BUSINESS WIRE)--Corsair Gaming, Inc. (Nasdaq: CRSR) today announced that its Elgato brand is bringing MCP support to Stream Deck, opening the award-winning platform to AI assistants for the first time. Starting with NVIDIA G-Assist, AI tools and agentic workflows can now execute actions on a user's system. This takes AI out of the chat box and gives it a presence in the real world. Most AI integrations today are screen-based. Chat windows, text fields, copilots that suggest th...

FORT MYERS, Fla.--(BUSINESS WIRE)--Juniper Landscaping ("Juniper" or the "Company") today announced it has acquired Hilton Head Landscapes, LLC ("Hilton Head Landscapes" or "HHL"), a leading landscape services provider based in South Carolina's Lowcountry region. The acquisition strengthens Juniper's presence in coastal South Carolina and builds on the Company's initial entry into the region through its 2024 acquisition of Davis Landscaping. Juniper is a portfolio company of Bregal Partners. Fo...

PITTSBURGH--(BUSINESS WIRE)--Life Science Connect ( “LSC”) is pleased to announce the appointment of Tony Cannon as its Chief Financial Officer. LSC welcomes Mr. Cannon to the team at a pivotal moment as the Company continues to strengthen its financial infrastructure and capabilities to support its continued growth. LSC is a portfolio company of Latticework Capital Management and Edgehill Management. LSC, headquartered in Pittsburgh, Pennsylvania, operates a network of trusted editorial commun...

CHESAPEAKE, Va.--(BUSINESS WIRE)--Dollar Tree, Inc. (NASDAQ: DLTR) today reported financial results for its first quarter ended May 2, 2026. “Our first quarter results reflect continued progress across the business and demonstrate the strength of Dollar Tree’s position as the preferred destination for value, convenience, and discovery,” said Mike Creedon, Chief Executive Officer. “We continued advancing our strategic plan – a more relevant assortment, agile cost management, a stronger customer...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the election of Kathleen Tregoning to its Board of Directors at the annual general meeting of shareholders. Ms. Tregoning is expected to serve on the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee. She brings extensive experience guiding bio...

LILLE, France--(BUSINESS WIRE)--Alzprotect today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for AZP2006 (Ezeprogind®) for the treatment of Progressive Supranuclear Palsy (PSP). FDA clearance permits the Company to begin clinical development of AZP2006 in the United States. “FDA IND clearance is a pivotal step in our PSP program,” said Philippe Verwaerde, PhD, President & Chief science Officer. “We can now e...

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI) announced the clinical findings of the Next-Generation PRRT, ¹⁷⁷Lu-DOTA-EB-TATE to treat GEP-NET Patients. The Phase 1 dose-escalation and dosimetry study will be presented at the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, taking place May 29–June 3, 2026, in Los Angeles, California. Neuroendocrine tumors (NETs) are often detected late, limiting curative treatments and requiring...